- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/70 - Enképhalines
Détention brevets de la classe C07K 14/70
Brevets de cette classe: 112
Historique des publications depuis 10 ans
|
9
|
15
|
11
|
6
|
8
|
16
|
6
|
14
|
2
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1126 |
17 |
| The Regents of the University of California | 20790 |
4 |
| The Trustees of the University of Pennsylvania | 4416 |
3 |
| Shattuck Labs, Inc. | 120 |
3 |
| Centre National de La Recherche Scientifique | 11042 |
2 |
| The Board of Trustees of the Leland Stanford Junior University | 6668 |
2 |
| Wisconsin Alumni Research Foundation | 3900 |
2 |
| Board of Regents, The University of Texas System | 6127 |
2 |
| The General Hospital Corporation | 4870 |
2 |
| Albert Einstein College of Medicine, Inc. | 596 |
2 |
| Alpine Immune Sciences, Inc. | 87 |
2 |
| Baylor College of Medicine | 1009 |
2 |
| Charite - Universitaetsmedizin Berlin | 26 |
2 |
| Charite - Universitatsmedizin Berlin | 385 |
2 |
| Instytut Farmakologii Polskiej Akademii Nauk | 9 |
2 |
| Mesoblast International Sàrl | 163 |
2 |
| Uniwersytet Warszawski | 167 |
2 |
| Inmatics Biotechnologies GmbH | 5 |
2 |
| Instytut Medycyny Doswiadczalnej I Klinicznej Im. | 2 |
2 |
| Artema Therapeutics, Inc. | 4 |
2 |
| Autres propriétaires | 53 |